Expert Opinion on Therapeutic Targets, Volume 26, Issue 9 (2022)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Therapeutic Targets, Volume 26, Issue 9 (2022)

See all volumes and issues
Vol 28, 2024 Vol 27, 2023 Volume 26, 2022 Vol 25, 2021 Vol 24, 2020 Vol 23, 2019 Vol 22, 2018 Vol 21, 2017 Vol 20, 2016 Vol 19, 2015 Vol 18, 2014 Vol 17, 2013 Vol 16, 2012 Vol 15, 2011 Vol 14, 2010 Vol 13, 2009 Vol 12, 2008 Vol 11, 2007 Vol 10, 2006 Vol 9, 2005 Vol 8, 2004 Vol 7, 2003 Vol 6, 2002 Vol 5, 2001 Vol 5, 2001 Vol 4, 2000 Vol 3, 1999 Vol 2, 1998 Vol 1, 1997
Download citations Download PDFs Download issue

Editorial

Editorial
MT1-MMP – A potential drug target for the management of the obesity
Pallavi Asthana, Xuanming Guo & Hoi Leong Xavier Wong
Pages: 761-765
Published online: 17 Nov 2022
First Page PreviewforMT1-MMP – A potential drug target for the management of the obesity | Full Text | References | PDF (4.1 MB) | EPUB
  • 1034 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical data
Maria Lina Tornesello, Anna Lucia Tornesello, Noemy Starita, Andrea Cerasuolo, Francesco Izzo, Luigi Buonaguro & Franco Maria Buonaguro
Pages: 767-780
Published online: 18 Nov 2022
AbstractforTelomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical data | Full Text | References | PDF (1.2 MB) | EPUB
  • 333 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
The molecular mechanisms and targeting strategies of transcription factors in cholangiocarcinoma
Jiao Wang, Fujing Ge, Tao Yuan, Meijia Qian, Fangjie Yan, Bo Yang, Qiaojun He & Hong Zhu
Pages: 781-789
Published online: 19 Oct 2022
AbstractforThe molecular mechanisms and targeting strategies of transcription factors in cholangiocarcinoma | Full Text | References | PDF (2.3 MB) | EPUB
  • 299 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
The adenosine A2A receptor is a therapeutic target in neurological, heart and oncogenic diseases
Rafael Franco, Alejandro Lillo, Gemma Navarro & Irene Reyes-Resina
Pages: 791-800
Published online: 26 Oct 2022
AbstractforThe adenosine A2A receptor is a therapeutic target in neurological, heart and oncogenic diseases | Full Text | References | PDF (784.8 KB) | EPUB
  • 296 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Identifying molecular mechanisms of acute to chronic pain transition and potential drug targets
Kannan Aravagiri, Adam Ali, Hank C Wang, Kenneth D Candido & Nebojsa Nick Knezevic
Pages: 801-810
Published online: 11 Nov 2022
AbstractforIdentifying molecular mechanisms of acute to chronic pain transition and potential drug targets | Full Text | References | PDF (638.6 KB) | EPUB
  • 288 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Preclinical target validation for non-addictive therapeutics development for pain
Richard Hargreaves, Karen Akinsanya, Seena K. Ajit, Neel T. Dhruv, Jamie Driscoll, Peter Farina, Narender Gavva, Marie Gill, Andrea Houghton, Smriti Iyengar, Carrie Jones, Annemieke Kavelaars, Ajamete Kaykas, Walter J. Koroshetz, Pascal Laeng, Jennifer M. Laird, Donald C. Lo, Johan Luthman, Gordon Munro, Michael L. Oshinsky, G. Sitta Sittampalam, Sarah A. Woller & Amir P. Tamiz
Pages: 811-822
Published online: 24 Nov 2022
AbstractforPreclinical target validation for non-addictive therapeutics development for pain | Full Text | References | PDF (1.4 MB) | EPUB
  • 254 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles